European Medicines Agency (EMA), has published its draft of ‘Regulatory Science to 2025’ strategy for a six-month public consultation, following the workshop organized last October. This “Reflection Paper” is a proposed plan for advancing the Agency’s engagement with regulatory science over the next five to ten years, covering both human and veterinary medicines. The strategy will […]
Gilda D’incerti, CEO of PQE Group has been appointed as Ambassador of the Territory for the Tuscany Region, for having actively contributed in stimulating the development and cohesion of the community, developing an idea of original and authentic future, without ever losing contact with the roots of the place. On the occasion of the ceremony […]
PQE awarded at Palazzo Montecitorio (Rome, Italy) with the Special Mention.
Thank you for visiting PQE Group at CPhI worldwide 2018 in Madrid! It was a great event: three days with over 45,000 pharma professionals from around the globe and more than 2,500 international exhibitors. Our stand held one of the most crowded party, with lottery, illusionists and many attendees. If you missed it, watch the video! […]
With a value of 122.6 billion dollars in 2017, which in 2022 will reach a figure of 145 and 175 billion dollars, the Chinese pharmaceutical market was the second largest in the world, after the US. A huge development that has not gone unnoticed by Alibaba, the Chinese colossus of e-commerce, who last June after […]
PQE earned a righteous spot in the FT 1000 2018 Ranking for the fastest growing companies in Europe.
Published today in the Official Bulletin of the State, the legislative decree number 101/2018 aligns Italy to the GDPR rules that have been released on May 25th. The decree will be active from September 19, 2018 and aims to bring a step forward for the transparency in the relations between patients and health service; as […]
PQE Group is proud to announce that the draft of the new Russian Guide for Industrial Data Integrity has been published on the website of GILS – Russian State Institute of Drugs and Good Practices. After the collaboration with COFEPRIS, the Mexican Regulatory Authority, for the creation of the data integrity chapter of the NOM […]
On Wednesday 27th of June has been presented at the 3rd PDA Europe Annual Meeting in Berlin a white paper about the issue of the Audit Trails Review. The ongoing theme of the European Annual Meeting is Global Healthcare of the Present & the Future, as it intends to continue spanning a bridge between current […]
PQE awarded as one of the fastest growing companies in Italy and Europe